Vaccinations and Screening for Pregnant Women by Trimester
All pregnant women should receive Tdap vaccine between 27-36 weeks gestation and influenza vaccine during any trimester, with screening for infectious diseases, aneuploidy, and neural tube defects distributed across all three trimesters according to optimal timing windows.
Vaccinations During Pregnancy
Routine Vaccinations for ALL Pregnant Women
Tdap (Tetanus, Diphtheria, Pertussis)
- Timing: 27-36 weeks gestation (third trimester), preferably 27-28 weeks 1
- Given with EVERY pregnancy, regardless of prior vaccination history
- This timing maximizes maternal antibody transfer to the infant, as active transport of IgG doesn't substantially occur before 30 weeks gestation 1
- If not given during pregnancy, administer immediately postpartum 1
Influenza (Inactivated)
- Timing: ANY trimester 2, 3
- One dose of seasonal inactivated influenza vaccine
- Pregnant women face 7.2% higher hospitalization risk and disproportionately high mortality from influenza 2
- The vaccine protects both mother and provides passive antibody protection to the infant
COVID-19
- Timing: Any trimester 2, 4
- Recommended during pregnancy and up to 6 months postpartum if not vaccinated during pregnancy 4
RSV (Respiratory Syncytial Virus)
- Timing: 24-36 weeks gestation, preferably 32-36 weeks 4
- This is a newer recommendation using RSVPreF vaccine
Special Situation Vaccinations
Hepatitis B
- Can be given during pregnancy if the woman is at risk or has incomplete vaccination 5
- Pregnancy is NOT a contraindication - the vaccine contains only noninfectious HBsAg particles 5
Tetanus/Diphtheria Booster (if >10 years since last dose)
- Replace with Tdap, optimally at 27-36 weeks 1
Contraindicated Vaccinations
Live attenuated vaccines are CONTRAINDICATED:
- MMR (Measles, Mumps, Rubella)
- Varicella
- Live attenuated influenza vaccine (nasal spray)
- BCG
- Oral typhoid 5
Important caveat: If immediate protection against poliomyelitis or yellow fever is needed due to imminent exposure, these may be given despite being live vaccines, as the risk-benefit favors vaccination 5
Screening Tests by Trimester
First Trimester Screening (Weeks 1-13)
Infectious Disease Screening (at first prenatal visit):
- HIV - screen all pregnant women as early as possible 6
- Hepatitis B surface antigen (HBsAg) - universal screening 5, 6
- Syphilis serology - universal screening 6
- Chlamydia - screen all women at onset of prenatal care 6
- Gonorrhea - screen women at risk or in high-prevalence areas 6
Aneuploidy Screening (11-13 weeks):
- Combined first trimester screening includes:
- Risk cut-off typically 1:200 (equivalent to 35-year-old patient risk in first trimester) 8
- PAPP-A is most discriminatory at 9 weeks gestation 8
Second Trimester Screening (Weeks 14-27)
Neural Tube Defect Screening (16-18 weeks optimal):
- MSAFP (Maternal Serum Alpha-Fetoprotein) - offered to all women for detection of open neural tube defects and anencephaly 7
Aneuploidy Screening (15-20 weeks):
- Quad screen (if not done in first trimester):
- AFP
- hCG
- Unconjugated estriol (uE3)
- Inhibin-A (INH-A) 7
- Risk cut-off typically 1:270 (second trimester risk equivalent to 35-year-old) 8
- Screen-positive results warrant genetic counseling and amniocentesis offer 7
Repeat Infectious Disease Screening:
- Chlamydia - repeat in third trimester for women <25 years or at increased risk 6
- Gonorrhea - repeat in third trimester for those who continue to be at risk 6
Third Trimester Screening (Weeks 28-40)
Infectious Disease Screening:
- Chlamydia - for women <25 years or at increased risk 6
- Gonorrhea - for those at continued risk 6
- Group B Streptococcus (GBS) - typically screened at 35-37 weeks (based on general medical knowledge, though not explicitly in provided evidence)
Genital Herpes Simplex Virus:
- Screening is by history and examination for lesions throughout pregnancy
- Routine serology NOT recommended 6
- Suppressive therapy with acyclovir or valacyclovir from 36 weeks reduces viral shedding at delivery 6
Critical Implementation Points
Common Pitfalls to Avoid:
Don't delay Tdap to postpartum - the goal is passive antibody transfer to the infant, which requires vaccination during pregnancy 1
Don't skip influenza vaccine due to trimester concerns - it can be given in any trimester, and delaying may leave high-risk women unprotected 5
Don't rescreen with repeat samples for aneuploidy unless there's suspected sample mix-up or the initial sample was collected too early 8
Don't treat asymptomatic bacterial vaginosis or trichomoniasis - current evidence shows treatment doesn't improve pregnancy outcomes 6
Accurate gestational age is critical for aneuploidy screening interpretation - ultrasound dating (crown-rump length in first trimester, BPD in second) is more accurate than last menstrual period 7, 8
For Women with Incomplete Vaccination History:
- If never vaccinated against tetanus: give 3-dose series at 0,4 weeks, and 6-12 months, with Tdap replacing one dose preferably at 27-36 weeks 1
Postpartum Vaccination: